Exicure (XCUR) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free XCUR Stock Alerts $0.48 0.00 (-0.02%) (As of 01:02 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 1:24 PM | finance.yahoo.comExicure, Inc. (XCUR)May 16, 2024 | investorplace.comXCUR Stock Earnings: Exicure Reported Results for Q3 2023May 16, 2024 | finance.yahoo.comExicure, Inc. Reports Third Quarter 2023 Financial ResultsMay 16, 2024 | businesswire.comExicure, Inc. Reports Third Quarter 2023 Financial ResultsMay 16, 2024 | americanbankingnews.comNewAmsterdam Pharma (NASDAQ:NAMS) and Exicure (NASDAQ:XCUR) Head to Head ReviewApril 24, 2024 | investing.comExicure faces Nasdaq non-compliance over delayed filingApril 22, 2024 | businesswire.comExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-KFebruary 22, 2024 | benzinga.comExicure Stock (NASDAQ:XCUR), Short Interest ReportFebruary 6, 2024 | benzinga.comWhy FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionFebruary 6, 2024 | msn.comWhy Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving PremarketFebruary 6, 2024 | msn.comExicure Inc Announces Licensing Patents for Therapeutic AdvancementFebruary 5, 2024 | marketwatch.comExicure, Bluejay Therapeutics Enter Patent License Agreement to Develop Hepatitis TreatmentFebruary 5, 2024 | finance.yahoo.comExicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of HepatitisFebruary 1, 2024 | msn.comBest Undervalued Stocks for February 2024December 16, 2023 | ca.finance.yahoo.comExicure, Inc. (XCUR) Stock Price, News, Quote & History - Yahoo FinanceDecember 8, 2023 | investorplace.comWhy Is Exicure (XCUR) Stock Up 57% Today?November 28, 2023 | msn.comExicure receives Nasdaq delinquency notice on late filing of its form 10-QNovember 9, 2023 | morningstar.comExicure Inc XCURAugust 29, 2023 | finance.yahoo.comLacklustre Performance Is Driving Exicure, Inc.'s (NASDAQ:XCUR) 25% Price DropAugust 23, 2023 | msn.comExicure names new CEO, CFO, directors in wake of resignationsAugust 15, 2023 | finance.yahoo.comExicure First Half 2023 Earnings: US$1.38 loss per share (vs US$3.71 loss in 1H 2022)August 11, 2023 | marketwatch.comExicure: Substantial Financing Needed to Continue OperationsAugust 11, 2023 | businesswire.comExicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateJuly 14, 2023 | finance.yahoo.comExicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 26, 2023 | msn.comExicure board backs CEO Kim's strategic alternative view for companyMay 26, 2023 | finance.yahoo.comExicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic AlternativesMay 25, 2023 | sg.finance.yahoo.comExicure, Inc. (XCUR) stock price, news, quote & history – Yahoo FinanceMay 19, 2023 | seekingalpha.comExicure gets Nasdaq non-compliance notice for not filing 10-QApril 27, 2023 | finance.yahoo.comExicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of DirectorsMarch 28, 2023 | wsj.comExicure Warns of Need to Raise Additional Funds to Keep OperatingMarch 28, 2023 | finance.yahoo.comExicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate UpdateMarch 20, 2023 | investing.comExicure (XCUR) Earnings Dates & ReportsJanuary 15, 2023 | finance.yahoo.comExicure, Inc. (XCUR) Stock Historical Prices & Data - Yahoo FinanceNovember 15, 2022 | ca.finance.yahoo.comExicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 15, 2022 | marketwatch.comExicure Warns of Needing Bankruptcy Protection if Deal with CBI USA FailsNovember 14, 2022 | marketbeat.comTrading was temporarily halted for "XCUR" at 04:11 PM with a stated reason of "News pending."September 28, 2022 | finance.yahoo.comExicure Lays Off Two-Third Employees, Ceases R&D ActivitiesSeptember 27, 2022 | uk.investing.comJabil, TD Synnex And 3 Stocks To Watch Heading Into Tuesday By Benzinga - Investing.com UKSeptember 26, 2022 | benzinga.comExicure shares are trading higher after the company announced a workforce reduction and a private placeme - BenzingaSeptember 26, 2022 | investing.comAfter-Hours Movers: Nautilus Gains on Strategic Review By Investing.com - Investing.comSeptember 26, 2022 | seekingalpha.comExicure to get $5.4M equity financing, reduce workforce & end R&D, preclinical activities - Seeking AlphaSeptember 26, 2022 | businesswire.comExicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives - Business WireSeptember 26, 2022 | marketbeat.comTrading was temporarily halted for "XCUR" at 04:09 PM with a stated reason of "News pending."September 25, 2022 | reuters.comXCUR.N - Exicure Inc | Stock Price & Latest News | ReutersSeptember 15, 2022 | reuters.comXCUR.OQ - Exicure Inc | Stock Price & Latest News | ReutersSeptember 1, 2022 | businesswire.comExicure Announces Presentation at Chardan's 6th Annual Genetic Medicines Conference - Business WireAugust 30, 2022 | msn.comWhy Baudax Bio Is Trading Lower By 34%; Here Are 26 Stocks Moving Premarket - msnNOWAugust 18, 2022 | seekingalpha.comExicure (XCUR) Investor Presentation - SlideshowAugust 16, 2022 | marketscreener.comChardan Adjusts Exicure's Price Target to $2 on 1-for-30 Reverse Stock Split, Maintains Neutral Rating - Marketscreener.comAugust 16, 2022 | businesswire.comExicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress - Business Wire Get Exicure News Delivered to You Automatically Sign up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… XCUR Media Mentions By Week XCUR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XCUR News Sentiment▼0.310.44▲Average Medical News Sentiment XCUR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XCUR Articles This Week▼50▲XCUR Articles Average Week Get Exicure News Delivered to You Automatically Sign up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Tharimmune News Clever Leaves News Alzamend Neuro News GT Biopharma News Cyclacel Pharmaceuticals News Petros Pharmaceuticals News Ensysce Biosciences News Soligenix News Seelos Therapeutics News ZyVersa Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XCUR) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account Before It’s Too LateWeiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exicure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
